Acute ischemic stroke (AIS) is a neurological emergency that accounts for the majority of stroke cases worldwide and continues to be one of the leading causes of long-term disability and mortality. The ability to rapidly and accurately diagnose AIS has a direct impact on clinical outcomes, as timely administration of thrombolytic therapy and mechanical thrombectomy significantly improves survival and functional recovery. Magnetic Resonance Imaging (MRI) has emerged as an indispensable diagnostic tool in the evaluation of AIS, providing greater sensitivity and specificity than conventional computed tomography (CT). Unlike CT, MRI is capable of detecting ischemic changes within minutes of onset, enabling clinicians to differentiate between infarcted tissue and salvageable penumbra. Techniques such as diffusion-weighted imaging (DWI), perfusion-weighted imaging (PWI), magnetic resonance angiography (MRA), and functional MRI (fMRI) provide comprehensive insights into stroke pathology and treatment planning. This paper explores the theoretical basis and clinical implications of MRI as a critical tool in AIS assessment, emphasizing its diagnostic superiority, prognostic value, limitations, and future directions in clinical practice.